| |
| |
|
| Insider
Information: |
Arthur David J. |
| Relationship: |
Chief Executive Office... |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
48,019 |
|
|
Indirect Shares
|
1,116 |
|
|
| Direct
Value |
$29,138 |
|
|
|
Indirect Value
|
$677 |
|
|
| Total
Shares |
49,135 |
|
|
| Total
Value |
$29,815 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salarius Pharmaceuticals, Inc |
SLRX |
Chief Executive Office... |
2023-02-13 |
48,019 |
2023-02-13 |
1,116 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
14,300 |
48,019 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
33,719 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-11-03 |
4/A |
A |
$1.73 |
$4,670 |
D/D |
2,693 |
13,719 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-11-03 |
4/A |
A |
$1.73 |
$17,340 |
D/D |
10,000 |
21,026 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-11-03 |
4 |
A |
$1.73 |
$17,340 |
D/D |
10,000 |
285,674 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-05-26 |
4 |
B |
$0.18 |
$3,987 |
I/I |
21,900 |
303,574 |
2.58 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-05-26 |
4 |
B |
$0.18 |
$3,997 |
D/D |
22,000 |
281,674 |
2.73 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2022-03-03 |
4 |
B |
$0.39 |
$54,540 |
D/D |
139,488 |
249,674 |
2.81 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2021-11-03 |
4 |
A |
$0.72 |
$5,700 |
D/D |
7,939 |
110,186 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2021-08-17 |
4 |
B |
$0.89 |
$3,582 |
I/I |
4,000 |
102,247 |
2.58 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2021-05-03 |
4 |
A |
$0.57 |
$5,569 |
D/D |
9,822 |
96,247 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2020-11-03 |
4 |
A |
$0.56 |
$2,737 |
D/D |
4,879 |
86,425 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2020-08-19 |
4 |
B |
$1.01 |
$2,020 |
I/I |
2,000 |
2,000 |
2.58 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2020-02-11 |
4 |
B |
$1.15 |
$2,501 |
D/D |
2,175 |
81,546 |
2.73 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Chief Executive OfficerOfficer |
• • – |
2019-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,371 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
